Clinical Trial Update: Additional Screening With Sensitives RDTs and Malaria [Phase 3]

View source ↗

Summary

Phase 3 trial update exploring additional screening with Sensitives rapid diagnostic tests for Plasmodium falciparum malaria and malaria diagnosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria Diagnosis
• Plasmodium Falciparum Malaria

Snippet

Sponsor: Institut de Recherche en Sciences de la Sante, Burkina Faso | Conditions: Plasmodium Falciparum Malaria, Malaria Diagnosis | Phase 3 | Status: COMPLETED